文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

UPP1 通过诱导免疫抑制微环境促进肺腺癌进展。

UPP1 promotes lung adenocarcinoma progression through the induction of an immunosuppressive microenvironment.

机构信息

Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.

Laboratory of Allergy and Precision Medicine, Chengdu Institute of Respiratory Health, Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu, 610031, Sichuan, China.

出版信息

Nat Commun. 2024 Feb 8;15(1):1200. doi: 10.1038/s41467-024-45340-w.


DOI:10.1038/s41467-024-45340-w
PMID:38331898
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10853547/
Abstract

The complexity of the tumor microenvironment (TME) is a crucial factor in lung adenocarcinoma (LUAD) progression. To gain deeper insights into molecular mechanisms of LUAD, we perform an integrative single-cell RNA sequencing (scRNA-seq) data analysis of 377,574 cells from 117 LUAD patient samples. By linking scRNA-seq data with bulk gene expression data, we identify a cluster of prognostic-related UPP1 tumor cells. These cells, primarily situated at the invasive front of tumors, display a stronger association with the immunosuppressive components in the TME. Our cytokine array analysis reveals that the upregulation of UPP1 in tumor cells leads to the increased release of various immunosuppressive cytokines, with TGF-β1 being particularly prominent. Furthermore, this UPP1 upregulation also elevates the expression of PD-L1 through the PI3K/AKT/mTOR pathway, which contributes to the suppression of CD8 + T cells. Cytometry by time-of-flight (CyTOF) analysis provides additional evidence of the role of UPP1 in shaping the immunosuppressive nature of the TME. Using patient-derived organoids (PDOs), we discover that UPP1 tumors exhibit relatively increased sensitivity to Bosutinib and Dasatinib. Collectively, our study highlights the immunosuppressive role of UPP1 in LUAD, and these findings may provide insights into the molecular features of LUAD and facilitate the development of personalized treatment strategies.

摘要

肿瘤微环境(TME)的复杂性是肺腺癌(LUAD)进展的关键因素。为了更深入地了解 LUAD 的分子机制,我们对 117 名 LUAD 患者样本中的 377,574 个细胞进行了综合单细胞 RNA 测序(scRNA-seq)数据分析。通过将 scRNA-seq 数据与批量基因表达数据相关联,我们确定了与 LUAD 预后相关的 UPP1 肿瘤细胞簇。这些细胞主要位于肿瘤的侵袭前沿,与 TME 中的免疫抑制成分有更强的关联。我们的细胞因子阵列分析表明,肿瘤细胞中 UPP1 的上调导致各种免疫抑制细胞因子的释放增加,其中 TGF-β1 尤为突出。此外,这种 UPP1 的上调还通过 PI3K/AKT/mTOR 通路增加了 PD-L1 的表达,从而抑制了 CD8+T 细胞。飞行时间(CyTOF)分析的细胞术提供了 UPP1 在塑造 TME 免疫抑制性质中的作用的额外证据。使用患者来源的类器官(PDOs),我们发现 UPP1 肿瘤对 Bosutinib 和 Dasatinib 的敏感性相对增加。总的来说,我们的研究强调了 UPP1 在 LUAD 中的免疫抑制作用,这些发现可能为 LUAD 的分子特征提供新的见解,并有助于制定个性化的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6968/10853547/ebe70edce6bc/41467_2024_45340_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6968/10853547/44215f62720d/41467_2024_45340_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6968/10853547/8f3861410f77/41467_2024_45340_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6968/10853547/fddb7a7963c7/41467_2024_45340_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6968/10853547/3862fb474416/41467_2024_45340_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6968/10853547/bc99a5a61f77/41467_2024_45340_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6968/10853547/1f97da6c631d/41467_2024_45340_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6968/10853547/ebe70edce6bc/41467_2024_45340_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6968/10853547/44215f62720d/41467_2024_45340_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6968/10853547/8f3861410f77/41467_2024_45340_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6968/10853547/fddb7a7963c7/41467_2024_45340_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6968/10853547/3862fb474416/41467_2024_45340_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6968/10853547/bc99a5a61f77/41467_2024_45340_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6968/10853547/1f97da6c631d/41467_2024_45340_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6968/10853547/ebe70edce6bc/41467_2024_45340_Fig7_HTML.jpg

相似文献

[1]
UPP1 promotes lung adenocarcinoma progression through the induction of an immunosuppressive microenvironment.

Nat Commun. 2024-2-8

[2]
COL3A1-positive endothelial cells influence LUAD prognosis and regulate LUAD carcinogenesis by NCL-PI3K-AKT axis.

J Gene Med. 2024-1

[3]
Single-cell RNA-sequencing uncovers the dynamic changes of tumour immune microenvironment in advanced lung adenocarcinoma.

BMJ Open Respir Res. 2023-12-11

[4]
Immune and non-immune cell subtypes identify novel targets for prognostic and therapeutic strategy: A study based on intratumoral heterogenicity analysis of multicenter scRNA-seq datasets in lung adenocarcinoma.

Front Immunol. 2022

[5]
Single-cell RNA sequencing reveals the effects of anti-PD-L1 therapy on 3LL lung cancer model and its tumor microenvironment.

Med Oncol. 2023-8-31

[6]
Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma.

J Immunother Cancer. 2022-1

[7]
Heterogeneity of tumor immune microenvironment of EGFR/ALK-positive tumors versus EGFR/ALK-negative tumors in resected brain metastases from lung adenocarcinoma.

J Immunother Cancer. 2023-3

[8]
Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma.

Front Immunol. 2021

[9]
Single-cell analysis reveals exosome-associated biomarkers for prognostic prediction and immunotherapy in lung adenocarcinoma.

Aging (Albany NY). 2023-10-24

[10]
Integrative Analyses of Pyrimidine Salvage Pathway-Related Genes Revealing the Associations Between UPP1 and Tumor Microenvironment.

J Inflamm Res. 2024-1-6

引用本文的文献

[1]
Cuproptosis-Related Gene FDX1 Induces Malignant Progression and Immune Suppression in Triple-Negative Breast Cancer.

Biochem Genet. 2025-9-5

[2]
Unraveling tumor cell‑tumor microenvironment crosstalk through antibody array technologies (Review).

Int J Oncol. 2025-10

[3]
Deciphering the tumor ecosystem dynamics undergoing immunochemotherapy therapy across multiple cancer types unveils the immunosuppressive role of S100A4 in fibroblasts by promoting PD-L1 expression in tumor cells.

Front Cell Dev Biol. 2025-7-23

[4]
The Role of Uridine in Health and Disease.

J Inflamm Res. 2025-7-29

[5]
Uridine phosphorylase-1 supports metastasis by altering immune and extracellular matrix landscapes.

EMBO Rep. 2025-7-23

[6]
Integration of single cell and bulk transcriptomes identifies T cell stress subtypes in LUAD.

Discov Oncol. 2025-7-17

[7]
Tumor-secreted RGS17 impairs CD8 + T cell function in lung adenocarcinoma through affecting glucose metabolism mediated by PI3K/AKT pathway.

Discov Oncol. 2025-7-8

[8]
Machine learning developed an immune evasion signature for predicting prognosis and immunotherapy benefits in lung adenocarcinoma.

Front Cell Dev Biol. 2025-6-19

[9]
First-line treatment options for PD-L1-negative lung adenocarcinoma: a real-world analysis.

Front Oncol. 2025-6-4

[10]
STAU1 exhibits oncogenic characteristics and modulates alternative splicing and gene expression in lung adenocarcinoma cells.

Sci Rep. 2025-5-16

本文引用的文献

[1]
Suppression of angiopoietin-like 4 reprograms endothelial cell metabolism and inhibits angiogenesis.

Nat Commun. 2023-12-12

[2]
Intravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lung.

Nat Commun. 2023-10-4

[3]
Macrophages in immunoregulation and therapeutics.

Signal Transduct Target Ther. 2023-5-22

[4]
Uridine-derived ribose fuels glucose-restricted pancreatic cancer.

Nature. 2023-6

[5]
Salvage of ribose from uridine or RNA supports glycolysis in nutrient-limited conditions.

Nat Metab. 2023-5

[6]
Increases prognostic value of clinical-pathological nomogram in patients with esophageal squamous cell carcinoma.

Front Oncol. 2023-2-14

[7]
A neurodevelopmental epigenetic programme mediated by SMARCD3-DAB1-Reelin signalling is hijacked to promote medulloblastoma metastasis.

Nat Cell Biol. 2023-3

[8]
Liver tumour immune microenvironment subtypes and neutrophil heterogeneity.

Nature. 2022-12

[9]
Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment.

Nat Commun. 2022-11-4

[10]
UPP1 Promotes Lung Adenocarcinoma Progression through Epigenetic Regulation of Glycolysis.

Aging Dis. 2022-10-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索